At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia
In Brief
A clinical study evaluating Small incision lenticule extraction, Tobramycin and dexamethasone, and 3 other interventions for Myopia and Refractive Errors. Completed, enrolled 114 participants across 1 site.
Detailed Summary
The purpose of this study is to validate the safety and effectiveness of treating myopia (short-sightedness) higher than -10D using small incision lenticule extraction (SMILE) with the VisuMax femtosecond laser.
Study Details
Timeline
Interventions
The VisuMax femtosecond laser is used to create two interfaces that define a refractive lenticule of stromal tissue and a 2mm wide tunnel to connect the upper layer to the corneal surface. The lenticule is manually dissected and removed through the small 2mm incision without the need to create a flap as in LASIK.
Tobramycin and dexamethasone (Tobradex) eye drops will be used four times a day for 1 week after the procedure
Ofloxacin (Exocin) eye drops will be used four times a day for 1 week after the procedure
Proxymetacaine 0.5% eye drops will be used as an anaesthetic during the procedure
Oxybuprocaine 0.4% eye drops will be used as an anaesthetic during the procedure